Organization Overview
Historical Acquisition Tree
Alternative names
delafloxacin meglumine (baxdela) (2017 NDA)
oritavancin (orbactiv) (2014 NDA)
Key: Melinta Therapeutics (2) Acquired (11)
Key: Melinta Therapeutics (3) Acquired (5)
Key: Melinta Therapeutics (2) Acquired (2)
Bacterial Infections (Phase 3)
Cellulitis (Phase 2)
Communicable Diseases (Phase 3)
Gonorrhea (Phase 3)
Infections (Phase 3)
Liver Diseases (Phase 1)
Pneumonia (Phase 3)
Pneumonia, Bacterial (Phase 3)
Skin Diseases (Phase 2)
Skin Diseases, Bacterial (Phase 2)
Skin Diseases, Infectious (Phase 2)
Soft Tissue Infections (Phase 3)
Staphylococcal Skin Infections (Phase 2)
Streptococcal Infections (Phase 2)